What is Delsys?
Delsys is a specialized company focused on the design, manufacturing, and marketing of advanced products for detecting and measuring electrical signals from muscle contractions. Their extensive product line includes EKG sensors, Accelerometers, Foot sensors, Goniometers, and a variety of other Biosignal sensors. With over 1200 centers globally utilizing Delsys technology, the company serves critical applications across research laboratories for neuromuscular system exploration, clinical settings for injury assessment and rehabilitation monitoring, sports science for performance enhancement, ergonomics for human-machine interaction optimization, and biofeedback for stress reduction and movement pattern relearning.
How much funding has Delsys raised?
Delsys has raised a total of $1.6M across 2 funding rounds:
Debt
$1M
Debt
$582K
Debt (2020): $1M with participation from PPP
Debt (2021): $582K led by PPP
Key Investors in Delsys
PPP
Public-Private Partnership
PPP
Public-Private Partnership
Undisclosed Investors
What's next for Delsys?
The recent major strategic investment signals Delsys's intent to further solidify its market leadership and potentially expand its technological capabilities or market reach. Given the enterprise-level nature of the capital infusion and the company's established presence, Delsys is likely poised for continued innovation in biosignal sensing technology, possibly exploring new applications or enhancing existing product lines to meet evolving demands in healthcare, performance, and industrial sectors. This backing will support ongoing research and development, ensuring Delsys remains at the forefront of neuromuscular system analysis and measurement.
See full Delsys company page
